New inflammation inhibitor discovered
Crystal structure of the protein OGG1 bound to a key inhibitor. Illustration: Geoffrey Masuyer “We’ve developed a new drug molecule that inhibits inflammation,” says Professor Thomas Helleday, at the Department of Oncology-Pathology, Karolinska Institutet, Sweden, who led the study. The enzyme OGG1 triggers inflammation It was when developing a new molecule for inhibiting the enzyme… Read More »